[COVID-19 and the hope for immunity].
作者信息
Aguilar-Shea Antonio L, Gallardo-Mayo Cristina
机构信息
Medicina Familiar y Comunitaria, Centro de Salud Puerta de Madrid, Dirección Asistencial Este, Atención Primaria de Madrid, Alcalá de Henares, Madrid, España.
Servicio de Anestesiología, Reanimación y Terapéutica del dolor, Hospital Universitario Infanta Leonor, Madrid, España.
出版信息
Aten Primaria. 2020 Oct;52(8):593-594. doi: 10.1016/j.aprim.2020.05.004. Epub 2020 May 25.
Abstract
摘要
相似文献
1
[COVID-19 and the hope for immunity].[新冠病毒肺炎与免疫的希望]
Aten Primaria. 2020 Oct;52(8):593-594. doi: 10.1016/j.aprim.2020.05.004. Epub 2020 May 25.
2
The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").基于新冠病毒免疫力的许可（“免疫通行证”）的伦理问题。
JAMA. 2020 Jun 9;323(22):2241-2242. doi: 10.1001/jama.2020.8102.
3
Herd immunity and COVID-19.群体免疫与新冠病毒病
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4064-4065. doi: 10.26355/eurrev_202004_20978.
4
Privileges and Immunity Certification During the COVID-19 Pandemic.新冠疫情期间的特权与豁免证明
JAMA. 2020 Jun 9;323(22):2243-2244. doi: 10.1001/jama.2020.7712.
5
Covid-19 and Immunity in Aging Populations - A New Research Agenda.新冠疫情与老年人群的免疫力——一项新的研究议程。
N Engl J Med. 2020 Aug 27;383(9):804-805. doi: 10.1056/NEJMp2006761. Epub 2020 Apr 17.
6
T cells found in coronavirus patients 'bode well' for long-term immunity.在新冠病毒患者体内发现的T细胞对长期免疫力“预示良好”。
Science. 2020 May 22;368(6493):809-810. doi: 10.1126/science.368.6493.809.
7
[Not Available].[无可用内容]。
Rev Med Suisse. 2020 Nov 11;16(714):2190.
8
Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?补充和替代医学能否通过改善免疫系统功能来有效治疗新冠病毒疾病？
J Infect Public Health. 2020 Jun;13(6):893-896. doi: 10.1016/j.jiph.2020.05.009. Epub 2020 May 20.
9
Immune status could be associated with severity in COVID-19 patients.免疫状态可能与新冠肺炎患者的病情严重程度相关。
Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):13-16. doi: 10.1590/1806-9282.66.S2.13. eCollection 2020.
10
Sweden's gamble.瑞典的冒险之举。
Science. 2020 Oct 9;370(6513):159-163. doi: 10.1126/science.370.6513.159.
本文引用的文献
1
[Coronavirus and primary care].[冠状病毒与初级医疗保健]
Aten Primaria. 2020 May;52(5):294-296. doi: 10.1016/j.aprim.2020.03.002. Epub 2020 Apr 6.
2
Phylogenetic network analysis of SARS-CoV-2 genomes.SARS-CoV-2 基因组的系统发育网络分析。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9241-9243. doi: 10.1073/pnas.2004999117. Epub 2020 Apr 8.
3
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.严重急性呼吸综合征冠状病毒2型与2019冠状病毒病：我们目前所了解的情况。
Pathogens. 2020 Mar 20;9(3):231. doi: 10.3390/pathogens9030231.
4
Why the immune system fails to mount an adaptive immune response to a COVID-19 infection.为何免疫系统无法对新冠病毒感染产生适应性免疫反应。
Transpl Int. 2020 Jul;33(7):824-825. doi: 10.1111/tri.13611. Epub 2020 Apr 25.
5
Transmission dynamics and evolutionary history of 2019-nCoV.2019-nCoV 的传播动力学和进化史。
J Med Virol. 2020 May;92(5):501-511. doi: 10.1002/jmv.25701. Epub 2020 Feb 14.
6
Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission.在人际传播早期获得的 SARS-CoV 29 个核苷酸缺失可减弱复制。
Sci Rep. 2018 Oct 11;8(1):15177. doi: 10.1038/s41598-018-33487-8.
Zotero 插件